Press Releases

Page Category: 

BOTHELL, WA - June 30, 2010 - SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that on June 30, 2010, it completed its acquisition of privately held VisualSonics , a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9 million net of cash and debt.

“This acquisition positions SonoSite for long-term growth in the pre-clinical and clinical point-of-care markets and enables the creation of potential breakthrough imaging products for both market spaces,” said Kevin M. Goodwin, SonoSite President and CEO. “With unmatched ultra high-frequency technology, which operates at five times the center frequency of a conventional ultrasound, VisualSonics’ micro-imaging technology has the potential to revolutionize clinical medicine and continue to transform pre-clinical research.”

“We are pleased to finalize this agreement with SonoSite,” said Anil Amlani, VisualSonics’ President and CEO. “SonoSite and VisualSonics share a passion for creating innovative products and driving new market opportunities.”

Under the terms of the agreement, VisualSonics will become a wholly-owned subsidiary of SonoSite, Inc. Shareholders of VisualSonics approved the acquisition.

About VisualSonics

BOTHELL, WA - June 29, 2010 - SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that the Company plans to host its second annual Analyst Day. The meeting will be held on Thursday, August 12, 2010, at the company’s headquarters in Bothell.

The Analyst Day offers SonoSite institutional and mutual fund investors the opportunity to hear from key members of SonoSite’s leadership team and learn more about the Company’s recent acquisition of VisualSonics. The agenda will also include a Q&A session with select members of the executive team.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound and industry leader in impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight ultrasound systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

UMI to Serve as a Distributor for SonoSite Products into Private Medical Offices

BOTHELL, WA - June 22 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound and United Medical Instruments (UMI), a worldwide provider of new and pre-owned ultrasound systems, today announced a new agreement for UMI to distribute SonoSite's products into certain small office markets. Under this relationship, UMI will act as an additional distributor of SonoSite's flagship M-Turbo® and MicroMaxx® ultrasound systems and will serve as a re-seller of SonoSite's used products from its older lines. This collaboration strongly positions SonoSite to continue to expand its presence in the office markets, while offering physicians greater access and customer support.

SonoSite's point-of-care ultrasound systems are designed to provide healthcare professionals with the ability to view anatomy in a greater variety of clinical settings. With the implementation of real-time visualization, physicians in office settings are able to confidently assess, diagnose and perform interventional procedures directly in the patient's examination room.

BOTHELL, WA - June 11, 2010 – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced a stock repurchase program under which the company may purchase up to $50 million of its common stock over the next twelve months. Since February 2010, SonoSite has repurchased a total of approximately 3 million shares of its common stock through a modified “Dutch Auction” tender offer at a total cost of $88.8 million.

SonoSite may repurchase its common stock from time to time, in amounts, at prices and at such times as it deems appropriate, all subject to market conditions and other considerations. SonoSite may make repurchases in the open market, in privately negotiated transactions, accelerated repurchase programs or in structured share repurchase programs. The repurchases will be conducted in compliance with the SEC’s Rule 10b-18 and applicable legal requirements and shall be subject to market conditions and other factors.

The company also expects to establish Rule 10b5-1 trading plans from time to time to effect such purchases when appropriate. The program does not obligate SonoSite to acquire any particular amount of common stock and the program may be modified or suspended at any time at the company’s discretion. Any repurchases would be funded from available cash on hand. As of March 31, 2010, SonoSite had approximately $178 million in cash, cash equivalents and short-term investment securities.

About SonoSite, Inc.

BOTHELL, WA – June 2, 2010 - SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, President and CEO, will present at the Jefferies 2010 Global Life Sciences Conference being held at the Grand Hyatt Hotel in New York City, June 8 – 11, 2010. Mr. Goodwin’s presentation will be webcast live on June 11, 2010 at 8:00 a.m. Eastern Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts . About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound and industry leader in impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight ultrasound systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

Technology Leader in Ultra High-Frequency Micro-Ultrasound, Visualsonics, Generated $30M in Trailing Twelve Month Revenues and $5M of EBITDAS. Company is a Leader in the $350M Pre-Clinical Imaging Research Market

Acquisition Stages Move of Ultra High-Frequency Ultrasound into Clinical Medicine

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - May 27, 2010 - SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held Visualsonics , a Toronto-based company focused on ultra high-frequency micro-ultrasound technology. The aggregate transaction value will be approximately $71 million net of cash and debt.

Visualsonics is the technology leader in real-time ultra high-frequency micro-ultrasound that presently serves the rapidly growing pre-clinical research market.

BOTHELL, WA – May 3, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, and Physio-Control, Inc., the global leader in the development and delivery of emergency medical response solutions, today announced a market development collaboration for point-of-care ultrasound in the emergency medical services (EMS) market. This alliance will enable SonoSite to expand its presence in the pre-hospital settings with the support of Physio-Control resources and extensive sales force. Under the terms of the agreement, the Physio-Control sales organization will assist in introducing SonoSite’s products to the EMS market .

The implementation of SonoSite’s hand-carried ultrasound systems allows first responders to bring improved care and immediate diagnostics directly to the point of patient care. With the ability to quickly assess, diagnose and triage patients at the scene of an accident, medical personnel in first response vehicles such as ambulances and helicopters will be able to pre-notify hospitals of a patient’s arrival, which could lead to improved clinical outcomes.

Management Projects Revenue Growth of 10-12% for the Full Year 2010 Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA – April 26, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the first quarter ended March 31, 2010.

REVENUE Revenues in the first quarter of 2010 were $56 million, an increase of 8% compared to the first quarter of 2009. Revenues from the recently acquired CardioDynamics (CDIC) were $3.2 million for the quarter. Revenues were up 2%, excluding CDIC, and included a 4% currency gain. "We saw some encouraging signs of improvement in our US hospital channel with year-over-year revenue growth of 12% and order booking rates that increased at a much faster rate," said Kevin M. Goodwin, SonoSite President and CEO. "With stable pricing, we delivered solid progress on EBIT with growth of 68% alongside an increase in EPS of 60%. We also experienced broadening success globally as 20 of 25 revenue regions achieved or exceeded forecast."

BOTHELL, WA - April 7, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that it will report the company’s first quarter financial results on Monday, April 26, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET. The call will be broadcast live and can be accessed via SonoSite’s website at http://www.sonosite.com/investorinformation/webcasts/ .

A replay of the audio webcast will be available beginning April 26, 2010 at 5:30 p.m. PT and can be accessed until May 10, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 4670785 is required to access the replay. Additionally, the call will be archived on SonoSite’s website.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound and industry leader in impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

SonoSite to distribute UltraLinq's web-based ultrasound image management and reporting service.

BOTHELL, WA - March 25, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care and UltraLinq Healthcare Solutions, Inc., a leader in web-based ultrasound and image study management, today announced a new distribution agreement. This partnership provides SonoSite with the exclusive right to market the UltraLinq service within Emergency Medicine and a non-exclusive right to market UltraLinq within other medical specialties.

"The decision to work with SonoSite was a logical evolution of our distribution strategy. SonoSite brings to UltraLinq unparalleled expertise within the point-of-care ultrasound market, and a national sales team which understands its customers. With expanded access, SonoSite's customers will benefit from UltraLinq's ability to deliver ‘Anytime, Anywhere Image Management & Reporting,'said UltraLinq's CEO, Stephen Farber.

"Recent technological advances have dramatically improved the capabilities and clinical flexibility of point-of-care ultrasound, bringing diagnostic imaging directly to the patient's bedside and other environments where ultrasound was not previously possible. UltraLinq facilitates the ability to access records from any location, whether in the next room or across the globe."